©
2013 City of Hope
1500 East Duarte Road
Duarte, CA 91010
626-256-HOPE (4673)
1500 East Duarte Road
Duarte, CA 91010
626-256-HOPE (4673)
A National Cancer Institute-designated Comprehensive Cancer Center
388px
Clinical Research Informatics
Clinical Research Informatics
Mission
The mission of Clinical Research Informatics (CRI)is to apply the science of information management to enable the effective and efficient execution of clinical research, including clinical trials, observational studies, and outcomes research.
The mission of Clinical Research Informatics (CRI)is to apply the science of information management to enable the effective and efficient execution of clinical research, including clinical trials, observational studies, and outcomes research.
Our key strategic goalis to build a world-class clinical research informatics infrastructure by implementing best-in-class commercial solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal, CRI led the selection and implementation of the best-in-class electronic data capture (EDC) solution for clinical trials with the Medidata Rave EDC.CRI has also deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.
Services
- Clinical Trials Management Systems (CTMS)
- Electronic Data Capture (EDC)
- Clinical Research Decision Support
Services
Clinical Trials Management Systems (CTMS)
Provide informatics solutions to manage the planning, execution, and reporting of clinical trials, such as protocol authoring, adverse event reporting, and subject enrollment
- CTMS Evaluation Project
- MIDAS
- Clinical Trials On-Line (CTOL)
Electronic Data Capture
Provide electronic data capture (EDC) systems with electronic case report forms (eCRFs) or computer-scannable CRFs to capture study data, such as adverse events and tumor response
- Medidata Rave EDC
-
TeleForms
Clinical Research Decision Support
Transforms data into decisions using business intelligence tools to report and analyze study-related data- Clinical Research Portal
- TeleForms Work Bench
- Clinical Trials On-Line (CTOL)
- Medidata Rave EDC (Business Objects)
- Automated Lab-Based Adverse Event Grader
- Engraftment for Outcomes Research Decision Support
Research Support Services
Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
In recognition of our excellence in a broad range of new approaches to cancer research and treatment—and our outreach to the community— the National Cancer Institute (NCI) has designated City of Hope a Comprehensive Cancer Center—one of just a handful of elite institutions nationwide.
City of Hope is a new model of cancer center, focused on rapidly transforming scientific discoveries into better treatments and better prevention strategies
What do you call 100 years of saving lives? At City of Hope, we call it a great beginning. Visit our Centennial website at
www.cityofhope.org
and share your story.
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases. Donate online or contact Donor Relations at donorrelations@coh.org or 800-720-6824.
NEWS & UPDATES
- One in a series of stories asking former patients to reflect upon their experience … Like many who face a cancer diagnosis, Kurt Deetz struggled at first with isolation, fear and depression. Told in 2009 that a malignant lump on his tonsil had spread to a lymph node, he worried about all that he would
- Prostate cancer is the second-leading cause of cancer death among men in the United States, according to the American Cancer Society, and more than 29,000 will die of the disease this year alone. A new City of Hope study suggests those numbers could ultimately be brought down. In findings being presented today...
- Months after hearing the arguments and weeks before concluding its current session, the Supreme Court unanimously ruled that human genes are a product of nature and are not patentable. In the court’s majority opinion, Justice Clarence Thomas wrote: “A naturally occurring DNA segment is a product of...
- As City of Hope celebrates its 100th anniversary, we offer a four-part interview with Art Riggs, Ph.D., chair of the Department of Diabetes and Metabolic Diseases Research. Many of City of Hope’s best-known breakthroughs came through his lab. In this series, he casts an eye back to some of his greatest scientif...
- Patients struggling to overcome blood cancers face a wider threat than just the malignant cells menacing their bodies. They also face challenging — even life-threatening — treatment side effects. For many patients undergoing bone marrow transplantation, graft versus host disease (GVHD) ranks as one of the most ...
- Though endometrial cancer is the most common gynecological cancer, there are no screening tests for the disease and only limited treatments for women whose cancer isn’t eliminated through surgery or radiation. But new City of Hope research could ultimately pave the way both for targeted treatments and screening...
- For breast cancer patients whose disease has spread to local lymph nodes, treatment may entail surgical removal of those nodes to decrease the likelihood of recurrence. But that procedure also comes with the risk of lymphedema, a painful swelling of the arm caused by retained fluids. However, findings from a re...
- Understanding how cells repair DNA damage is key to revealing the role of BRCA1 and other tumor suppressors and to overcoming chemotherapy resistance in cancer. City of Hope research just published in Nucleic Acids Research sheds light on this topic and could lead to improved therapies. Principal investigator ...
- The discovery of genes that may increase a woman’s risk of developing breast cancer has resulted in potentially powerful tools to guide care – but like all new technologies, there’s a learning curve. Many physicians surveyed for a newly released City of Hope study said that, although they feel confident orderin...
- Smita Bhatia has watched pediatric patients defeat cancer, only to see many of them grow into adult survivors confronting new deadly opponents: secondary cancers and serious health problems resulting from the lifesaving but toxic therapies they received as children. Bhatia, M.D., M.P.H., is the Ruth Ziegler Cha...
- Our ability to maintain brain function and preserve learning and memory are at the core of City of Hope research just published in Molecular Cell Biology. Here, lead author Yanhong Shi, Ph.D., an associate professor in the departments of Neurosciences and Radiation Biology, explains the significance of her pape...
- Each year in the United States, lung cancer kills more people than colon, breast and prostate cancers combined. When the least dangerous form of skin cancer is taken out of the equation, lung cancer is the second most-common cancer in both men and women, after prostate and breast cancer respectively. It’s also ...
- As City of Hope celebrates its 100th anniversary, we offer a four-part interview with Art Riggs, Ph.D., chair of the Department of Diabetes and Metabolic Diseases Research. Many of City of Hope’s best-known breakthroughs came through his lab. In this series, he casts an eye back to some of his greatest scientif...
- The importance of applying sunscreen to reduce the risk of skin cancer has been drilled into the public for the past few decades. Yet studies have shown that skin cancer rates continue to climb, with melanoma diagnoses rising nearly 2 percent a year since 2000. What are people doing wrong? Skin cancer expert Vi...
- The first question after a diagnosis of prostate cancer: Is the cancer slow-growing or fast-growing? A slow-growing prostate cancer can simply be monitored, enabling patients to avoid potential side effects of treatment for as long as possible. A fast-growing cancer demands immediate attention, regardless of th...
